Sangamo Therapeutics Shares Resume Trade
Portfolio Pulse from Benzinga Newsdesk
Sangamo Therapeutics shares have resumed trading after a temporary halt.

July 24, 2024 | 1:43 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Sangamo Therapeutics shares have resumed trading after a temporary halt.
The resumption of trading after a halt is a neutral event unless further context is provided. It indicates that any issues causing the halt have been resolved, but without additional information, the impact on the stock price is uncertain.
CONFIDENCE 90
IMPORTANCE 50
RELEVANCE 100